ACADIA Pharmaceuticals Inc. (ACAD)
USD 15.4
(-4.47%)
USD 15.4
(-4.47%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -131.45 Million USD | -148.75% |
| 2022 | -52.84 Million USD | 42.12% |
| 2021 | -91.3 Million USD | 67.57% |
| 2020 | -281.56 Million USD | -53.59% |
| 2019 | -183.31 Million USD | -36.04% |
| 2018 | -134.75 Million USD | -94.13% |
| 2017 | -69.41 Million USD | 57.57% |
| 2016 | -163.62 Million USD | -60.2% |
| 2015 | -102.13 Million USD | -65.13% |
| 2014 | -61.85 Million USD | -428.35% |
| 2013 | -11.7 Million USD | 79.78% |
| 2012 | -57.89 Million USD | -744.38% |
| 2011 | -6.85 Million USD | -1.75% |
| 2010 | -6.73 Million USD | 61.84% |
| 2009 | -17.65 Million USD | 11.47% |
| 2008 | -19.94 Million USD | -34.29% |
| 2007 | -14.85 Million USD | -13.34% |
| 2006 | -13.1 Million USD | -63.52% |
| 2005 | -8.01 Million USD | -38.86% |
| 2004 | -5.77 Million USD | -300.31% |
| 2003 | -1.44 Million USD | -172.8% |
| 2002 | 1.98 Million USD | 49.69% |
| 2001 | 1.32 Million USD | -77.15% |
| 2000 | 5.78 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -119.47 Million USD | 17.66% |
| 2024 Q1 | -145.1 Million USD | -10.38% |
| 2023 Q1 | -239.45 Million USD | -353.12% |
| 2023 Q4 | -131.45 Million USD | -162.43% |
| 2023 Q3 | -50.09 Million USD | 13.88% |
| 2023 FY | -131.45 Million USD | -148.75% |
| 2023 Q2 | -58.16 Million USD | 75.71% |
| 2022 Q2 | -76.11 Million USD | 45.82% |
| 2022 Q1 | -140.49 Million USD | -53.87% |
| 2022 FY | -52.84 Million USD | 42.12% |
| 2022 Q4 | -52.84 Million USD | 47.72% |
| 2022 Q3 | -101.07 Million USD | -32.79% |
| 2021 Q4 | -91.3 Million USD | -147.03% |
| 2021 Q1 | -243.9 Million USD | 13.38% |
| 2021 FY | -91.3 Million USD | 67.57% |
| 2021 Q2 | -207.82 Million USD | 14.79% |
| 2021 Q3 | -36.96 Million USD | 82.21% |
| 2020 Q4 | -281.56 Million USD | 30.16% |
| 2020 FY | -281.56 Million USD | -53.59% |
| 2020 Q1 | -166.96 Million USD | 8.92% |
| 2020 Q2 | -304.77 Million USD | -82.53% |
| 2020 Q3 | -403.15 Million USD | -32.28% |
| 2019 Q4 | -183.31 Million USD | 51.64% |
| 2019 Q2 | -67.69 Million USD | 25.45% |
| 2019 FY | -183.31 Million USD | -36.04% |
| 2019 Q3 | -379.09 Million USD | -460.05% |
| 2019 Q1 | -90.8 Million USD | 32.62% |
| 2018 FY | -134.75 Million USD | -94.13% |
| 2018 Q1 | -116.32 Million USD | -67.58% |
| 2018 Q2 | -74.18 Million USD | 36.23% |
| 2018 Q3 | -63.89 Million USD | 13.86% |
| 2018 Q4 | -134.75 Million USD | -110.9% |
| 2017 Q1 | -157.38 Million USD | 3.81% |
| 2017 Q2 | -143.78 Million USD | 8.64% |
| 2017 Q4 | -69.41 Million USD | 38.36% |
| 2017 FY | -69.41 Million USD | 57.57% |
| 2017 Q3 | -112.61 Million USD | 21.68% |
| 2016 Q3 | -153.67 Million USD | -16.62% |
| 2016 Q4 | -163.62 Million USD | -6.47% |
| 2016 Q2 | -131.77 Million USD | 24.8% |
| 2016 Q1 | -175.22 Million USD | -71.55% |
| 2016 FY | -163.62 Million USD | -60.2% |
| 2015 Q2 | -93.21 Million USD | -21.97% |
| 2015 Q3 | -70.79 Million USD | 24.05% |
| 2015 Q1 | -76.42 Million USD | -23.49% |
| 2015 Q4 | -102.13 Million USD | -44.26% |
| 2015 FY | -102.13 Million USD | -65.13% |
| 2014 Q3 | -36.36 Million USD | -165.51% |
| 2014 Q2 | -13.69 Million USD | 85.8% |
| 2014 Q4 | -61.88 Million USD | -70.16% |
| 2014 Q1 | -96.45 Million USD | -723.91% |
| 2014 FY | -61.85 Million USD | -428.35% |
| 2013 FY | -11.7 Million USD | 79.78% |
| 2013 Q1 | -18.43 Million USD | 68.16% |
| 2013 Q4 | -11.7 Million USD | 0.81% |
| 2013 Q3 | -11.8 Million USD | 51.32% |
| 2013 Q2 | -24.24 Million USD | -31.52% |
| 2012 FY | -57.89 Million USD | -744.38% |
| 2012 Q4 | -57.89 Million USD | -622.56% |
| 2012 Q3 | -8.01 Million USD | 12.85% |
| 2012 Q2 | -9.19 Million USD | -66.09% |
| 2012 Q1 | -5.53 Million USD | 19.26% |
| 2011 FY | -6.85 Million USD | -1.75% |
| 2011 Q4 | -6.85 Million USD | 17.19% |
| 2011 Q1 | -6.78 Million USD | -0.68% |
| 2011 Q2 | -7.98 Million USD | -17.61% |
| 2011 Q3 | -8.28 Million USD | -3.76% |
| 2010 Q3 | -9.5 Million USD | -10.52% |
| 2010 Q2 | -8.59 Million USD | 51.45% |
| 2010 FY | -6.73 Million USD | 61.84% |
| 2010 Q4 | -6.73 Million USD | 29.09% |
| 2010 Q1 | -17.71 Million USD | -0.29% |
| 2009 Q3 | -16.71 Million USD | 2.78% |
| 2009 Q2 | -17.19 Million USD | 3.56% |
| 2009 FY | -17.65 Million USD | 11.47% |
| 2009 Q1 | -17.83 Million USD | 10.6% |
| 2009 Q4 | -17.65 Million USD | -5.63% |
| 2008 Q3 | -20.83 Million USD | -11.59% |
| 2008 Q4 | -19.94 Million USD | 4.28% |
| 2008 FY | -19.94 Million USD | -34.29% |
| 2008 Q1 | -19.13 Million USD | -28.81% |
| 2008 Q2 | -18.67 Million USD | 2.4% |
| 2007 Q2 | -37.14 Million USD | -87.86% |
| 2007 Q4 | -14.85 Million USD | 29.91% |
| 2007 Q3 | -21.19 Million USD | 42.95% |
| 2007 Q1 | -19.77 Million USD | -50.88% |
| 2007 FY | -14.85 Million USD | -13.34% |
| 2006 Q2 | -36.71 Million USD | -277.45% |
| 2006 Q3 | -24.18 Million USD | 34.13% |
| 2006 Q4 | -13.1 Million USD | 45.81% |
| 2006 FY | -13.1 Million USD | -63.52% |
| 2006 Q1 | -9.72 Million USD | -21.36% |
| 2005 Q4 | -8.01 Million USD | 62.72% |
| 2005 FY | -8.01 Million USD | -38.86% |
| 2005 Q1 | -9.53 Million USD | -65.25% |
| 2005 Q2 | -14.13 Million USD | -48.25% |
| 2005 Q3 | -21.49 Million USD | -52.06% |
| 2004 Q3 | -2.6 Million USD | 43.4% |
| 2004 Q4 | -5.77 Million USD | -121.39% |
| 2004 Q1 | -324 Thousand USD | 77.53% |
| 2004 FY | -5.77 Million USD | -300.31% |
| 2004 Q2 | -4.6 Million USD | -1321.64% |
| 2003 Q4 | -1.44 Million USD | 0.0% |
| 2003 FY | -1.44 Million USD | -172.8% |
| 2002 FY | 1.98 Million USD | 49.69% |
| 2001 FY | 1.32 Million USD | -77.15% |
| 2000 FY | 5.78 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -134.987% |
| Alkermes plc | -166.73 Million USD | 21.163% |
| Agenus Inc. | 274.13 Million USD | 147.951% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 107.03% |
| Aptorum Group Limited | 1.35 Million USD | 9786.628% |
| Ardelyx, Inc. | 34.51 Million USD | 480.888% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 3171.308% |
| Bicycle Therapeutics plc | -481.46 Million USD | 72.698% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 463.499% |
| ChromaDex Corporation | -24.04 Million USD | -446.623% |
| Chimerix, Inc. | -25.51 Million USD | -415.155% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 1986.489% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -455.189% |
| CRISPR Therapeutics AG | -150.84 Million USD | 12.856% |
| Precision BioSciences, Inc. | -85.41 Million USD | -53.907% |
| Dyadic International, Inc. | -6.37 Million USD | -1960.99% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -725.03% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1814.964% |
| Lantern Pharma Inc. | -21.7 Million USD | -505.678% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -18.921% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -1438.678% |
| Incyte Corporation | -3.17 Billion USD | 95.86% |
| IO Biotech, Inc. | -140.69 Million USD | 6.572% |
| Jaguar Health, Inc. | 29.39 Million USD | 547.253% |
| Novavax, Inc. | -298.29 Million USD | 55.932% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 2563.032% |
| Opthea Limited | 28.15 Million USD | 566.846% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -682.965% |
| ContextLogic Inc. | -232 Million USD | 43.34% |
| MiMedx Group, Inc. | -33.9 Million USD | -287.753% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 1389.377% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -5573.305% |
| NextCure, Inc. | -6.47 Million USD | -1929.52% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -160.296% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -1960.699% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1180.729% |
| Vaxcyte, Inc. | -368.22 Million USD | 64.301% |
| PDS Biotechnology Corporation | -32.7 Million USD | -301.885% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 860.806% |
| Pharming Group N.V. | 109.8 Million USD | 219.715% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -655.645% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 24.983% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -609.79% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -609.79% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -1751.437% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -2143.208% |
| Acelyrin, Inc. | -216.9 Million USD | 39.396% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -2243.061% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -7524.826% |
| Summit Therapeutics Inc. | 34.67 Million USD | 479.108% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -1832.265% |
| Senti Biosciences, Inc. | 1.74 Million USD | 7654.713% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 28.794% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -69.723% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -2068.459% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 131856.357% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 21031.847% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -12.308% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 21.863% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 218.564% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -1630.542% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -1.811% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 2006.594% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 45.762% |
| Immix Biopharma, Inc. | -17.5 Million USD | -650.734% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 58.494% |
| MEI Pharma, Inc. | -3.7 Million USD | -3447.962% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1150.691% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 181.273% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 572.968% |
| Fortress Biotech, Inc. | 7.66 Million USD | 1814.964% |
| Precigen, Inc. | -481 Thousand USD | -27228.898% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1033.542% |
| AlloVir, Inc. | -62.69 Million USD | -109.679% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -136.365% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 313.168% |
| ImmuCell Corporation | 10.99 Million USD | 1296.044% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 14.722% |
| Onconetix, Inc. | 5.33 Million USD | 2565.602% |
| PureTech Health plc | -167.19 Million USD | 21.379% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -331.556% |
| Elevation Oncology, Inc. | -19.11 Million USD | -587.582% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -2577.776% |
| Seer, Inc. | -4.24 Million USD | -3000.283% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -446.874% |
| Innoviva, Inc. | 255.56 Million USD | 151.436% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -135.307% |
| ESSA Pharma Inc. | -33.62 Million USD | -290.975% |
| GlycoMimetics, Inc. | -40.98 Million USD | -220.736% |
| GT Biopharma, Inc. | -1.02 Million USD | -12774.829% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -93.931% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 314.591% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 1.959% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -848.701% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -355.292% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -174392.261% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -325.935% |
| Aptose Biosciences Inc. | -8.19 Million USD | -1504.079% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -4101.062% |
| Soligenix, Inc. | -4.95 Million USD | -2554.739% |
| Century Therapeutics, Inc. | 847 Thousand USD | 15619.717% |
| Kura Oncology, Inc. | -20.11 Million USD | -553.405% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -221.194% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -1465.277% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 7315.917% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -4011.73% |
| Autolus Therapeutics plc | -186.59 Million USD | 29.554% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -166.615% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 52.337% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 483.6% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 179.974% |
| GRI Bio, Inc. | -1.79 Million USD | -7227.313% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -1363.334% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -295.261% |
| IGM Biosciences, Inc. | -72.6 Million USD | -81.048% |
| INmune Bio, Inc. | -25.41 Million USD | -417.304% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 187.083% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -159.484% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -708.967% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -4456.512% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 445.79% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -219.174% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 512.269% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 134.78% |
| Verastem, Inc. | -37.27 Million USD | -252.626% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -1348.826% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -153.465% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -768.53% |
| Histogen Inc. | -7.48 Million USD | -1655.737% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -508.382% |
| Surrozen, Inc. | -32.66 Million USD | -302.437% |
| Organovo Holdings, Inc. | -1.5 Million USD | -8622.76% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -3027.212% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 793.305% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 5124.924% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 3262.945% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -1468.424% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -202.592% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -801.785% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 58.505% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -18105.135% |
| Apollomics, Inc. | -27.39 Million USD | -379.839% |
| Amarin Corporation plc | -191.04 Million USD | 31.191% |
| Mesoblast Limited | 55.96 Million USD | 334.891% |
| Turnstone Biologics Corp. | -14.58 Million USD | -801.344% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -419.737% |
| Synaptogenix, Inc. | -28.66 Million USD | -358.636% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -13944.017% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 369.745% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -15148.078% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -1709.119% |
| Exelixis, Inc. | -73.05 Million USD | -79.948% |
| Better Therapeutics, Inc. | -860 Thousand USD | -15185.116% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -447.42% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 45.539% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 17958.725% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -1667.271% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 10582.616% |
| Gritstone bio, Inc. | 39.49 Million USD | 432.874% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -56.303% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -4894.111% |
| Avid Bioservices, Inc. | 169.72 Million USD | 177.449% |
| Insmed Incorporated | 721.62 Million USD | 118.216% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -1337.968% |
| MediWound Ltd. | -5.32 Million USD | -2369.974% |
| OmniAb, Inc. | 9.2 Million USD | 1528.36% |
| Alector, Inc. | -35.63 Million USD | -268.864% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 252.903% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -2567.451% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1092.915% |
| Zai Lab Limited | -775 Million USD | 83.038% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 138.599% |
| Aura Biosciences, Inc. | -21.52 Million USD | -510.695% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -59.374% |
| Immunic, Inc. | -45.34 Million USD | -189.925% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 31.966% |
| Veracyte, Inc. | -203.82 Million USD | 35.507% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 120.594% |
| FibroGen, Inc. | 56.76 Million USD | 331.564% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1576.159% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -4549.741% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -6249.271% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 102.864% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -3834.511% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 20.795% |
| TG Therapeutics, Inc. | 17.86 Million USD | 835.931% |
| Galecto, Inc. | -21.21 Million USD | -519.589% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -452.668% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 108.376% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -437.153% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1042.366% |
| XBiotech Inc. | -200.02 Million USD | 34.282% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -56.303% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 3003.092% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -272.776% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -70.235% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 2409.823% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 22.864% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -42.304% |
| Vaxxinity, Inc. | 10.13 Million USD | 1397.394% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 117.854% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1120.816% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -99.303% |
| NexImmune, Inc. | -3.13 Million USD | -4094.862% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -3707.253% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -769.883% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -385.063% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -1364.474% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -105420.369% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -223.997% |
| Ainos, Inc. | 4.07 Million USD | 3323.5% |
| Pluri Inc. | 22.82 Million USD | 675.811% |
| Prothena Corporation plc | -608.34 Million USD | 78.392% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -10.691% |
| Celularity Inc. | 65.19 Million USD | 301.644% |
| Rallybio Corporation | -24.1 Million USD | -445.399% |
| Cue Biopharma, Inc. | -33.81 Million USD | -288.693% |
| MeiraGTx Holdings plc | -40.3 Million USD | -226.167% |
| Omeros Corporation | 331.17 Million USD | 139.692% |
| Humacyte, Inc. | -22.48 Million USD | -484.595% |
| Immunocore Holdings plc | -358.59 Million USD | 63.342% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -434.901% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -325.397% |
| Blueprint Medicines Corporation | 702.83 Million USD | 118.703% |
| CalciMedica, Inc. | -5.53 Million USD | -2277.071% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 30.16% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -1186.979% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -228.326% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -295.309% |
| Pulmatrix, Inc. | -10.41 Million USD | -1161.899% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -2099.297% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -244.638% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -17.998% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -119.291% |
| Cytokinetics, Incorporated | 642.37 Million USD | 120.464% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -2157.462% |
| Nutriband Inc. | -251.65 Thousand USD | -52134.589% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -285.275% |
| Vor Biopharma Inc. | 4.3 Million USD | 3157.023% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 97.822% |
| Evogene Ltd. | -19.63 Million USD | -569.512% |
| ProKidney Corp. | -56.23 Million USD | -133.751% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -170.077% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -1323.074% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 109.638% |
| CorMedix Inc. | -43.05 Million USD | -205.33% |
| BioLineRx Ltd. | 7.33 Million USD | 1891.876% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -378.616% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 384.855% |
| Atai Life Sciences N.V. | -28.55 Million USD | -360.298% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 5993.311% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -476.14% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 841.201% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -75.097% |
| MediciNova, Inc. | -50.78 Million USD | -158.848% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -66.807% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -584260.969% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1937.198% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 34.215% |
| Biomea Fusion, Inc. | -166.57 Million USD | 21.083% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 26.553% |
| Mereo BioPharma Group plc | -51.46 Million USD | -155.4% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -38.598% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 55.252% |
| Absci Corporation | -72.59 Million USD | -81.068% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 2978.931% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 43.929% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -39.529% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -37.364% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -236.427% |
| Allakos Inc. | -24.97 Million USD | -426.334% |
| Imunon, Inc. | -4.21 Million USD | -3019.521% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -791.684% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 2.916% |
| BioAtla, Inc. | -109.01 Million USD | -20.586% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 17958.725% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -13899.148% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1198.546% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -519.969% |
| XOMA Corporation | -29 Million USD | -353.283% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -693.792% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -1357.986% |
| aTyr Pharma, Inc. | -7.44 Million USD | -1664.693% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -5.469% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 36.852% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -60.741% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -41.707% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -15199.633% |
| Akari Therapeutics, Plc | -3.84 Million USD | -3318.778% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 8199.871% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 109.519% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -10963.726% |
| UroGen Pharma Ltd. | 4.39 Million USD | 3093.669% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 215.836% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 182768.631% |
| Orgenesis Inc. | 21.78 Million USD | 703.434% |
| Entera Bio Ltd. | -10.62 Million USD | -1136.73% |
| GH Research PLC | -78.07 Million USD | -68.362% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -489.788% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -393.087% |
| Xencor, Inc. | 29.64 Million USD | 543.435% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -6573.327% |
| Replimune Group, Inc. | 1.41 Million USD | 9409.632% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -53574.033% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -3.983% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -10963.726% |
| Portage Biotech Inc. | -4.98 Million USD | -2539.068% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -584260.969% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -98.802% |
| OncoCyte Corporation | -6.56 Million USD | -1902.925% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 14747.882% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -2785.476% |
| Purple Biotech Ltd. | -14.13 Million USD | -829.778% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -453.342% |
| scPharmaceuticals Inc. | -6.54 Million USD | -1908.434% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -687.507% |
| HilleVax, Inc. | -165.48 Million USD | 20.566% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -5079.354% |
| Tharimmune, Inc. | -10.93 Million USD | -1102.083% |
| Genprex, Inc. | -6.73 Million USD | -1851.013% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 64.358% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -48.6% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -9282.727% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -3863.043% |
| OKYO Pharma Limited | -826.84 Thousand USD | -15797.964% |
| Savara Inc. | 153 Thousand USD | 86016.34% |
| Curis, Inc. | -23.88 Million USD | -450.308% |
| Daré Bioscience, Inc. | -5.15 Million USD | -2448.551% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -16839.429% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -2017.461% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 11192.996% |
| BeiGene, Ltd. | -2.25 Billion USD | 94.166% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1165.381% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 78.387% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 29.169% |
| Erasca, Inc. | -37.21 Million USD | -253.214% |
| bluebird bio, Inc. | 108.57 Million USD | 221.075% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -10106.749% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 134.707% |
| DBV Technologies S.A. | -126.98 Million USD | -3.517% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -10106.749% |
| Moderna, Inc. | -2.9 Billion USD | 95.478% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1169.822% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1109.533% |
| Molecular Templates, Inc. | 707 Thousand USD | 18692.928% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -319.024% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 137.925% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -60.186% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -43.303% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -307.325% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -282.395% |
| MacroGenics, Inc. | -66.98 Million USD | -96.241% |
| RenovoRx, Inc. | -1.17 Million USD | -11106.479% |
| Adicet Bio, Inc. | -138.78 Million USD | 5.285% |
| Prime Medicine, Inc. | -27.94 Million USD | -370.463% |
| Aditxt, Inc. | 18.12 Million USD | 825.417% |
| Adagene Inc. | -87.62 Million USD | -50.012% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -3055.786% |
| Quantum-Si incorporated | -118.55 Million USD | -10.877% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 465.094% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -1658.746% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -170.985% |
| SciSparc Ltd. | -2.06 Million USD | -6265.714% |
| Vericel Corporation | 1.27 Million USD | 10393.814% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -996.191% |
| Minerva Neurosciences, Inc. | 41 Million USD | 420.581% |
| Generation Bio Co. | 31.44 Million USD | 517.998% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 25.04% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -325.095% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 212.744% |
| Invivyd, Inc. | -198.47 Million USD | 33.769% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -45.621% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -5382.447% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -85.693% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -1826.037% |
| 2seventy bio, Inc. | 181.71 Million USD | 172.34% |
| ADMA Biologics, Inc. | 90.06 Million USD | 245.951% |
| Clene Inc. | 3.34 Million USD | 4035.689% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -1347.278% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -511.092% |
| GeoVax Labs, Inc. | -6.45 Million USD | -1937.198% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 61.801% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -405.591% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 173.988% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -3112.754% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 2727.989% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -2423.555% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -0.881% |
| Evaxion Biotech A/S | 5.28 Million USD | 2586.398% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -16.776% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -0.136% |
| Trevena, Inc. | 2.25 Million USD | 5921.612% |
| Surrozen, Inc. | -32.66 Million USD | -302.437% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -155.197% |
| Cingulate Inc. | 3.08 Million USD | 4364.208% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -4375.724% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 1929.025% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -1314.797% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -65.717% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -24.549% |
| Clearmind Medicine Inc. | -3.94 Million USD | -3234.114% |
| Kronos Bio, Inc. | -36.05 Million USD | -264.598% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 1497.088% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 9115.127% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -142.281% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1011.822% |
| ImmunityBio, Inc. | 618.22 Million USD | 121.263% |
| Korro Bio, Inc. | -132.94 Million USD | 1.122% |
| Kineta, Inc. | -4.54 Million USD | -2794.781% |
| BioVie Inc. | -17.73 Million USD | -641.312% |
| Codexis, Inc. | -43.27 Million USD | -203.788% |
| Celularity Inc. | 65.19 Million USD | 301.644% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -4048.059% |
| Celcuity Inc. | 6.78 Million USD | 2037.817% |
| Virax Biolabs Group Limited | -3.36 Million USD | -3806.514% |
| Cibus, Inc. | -8.07 Million USD | -1527.284% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -3008.347% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 2976.411% |
| IN8bio, Inc. | -16.38 Million USD | -702.075% |
| Kodiak Sciences Inc. | -103.87 Million USD | -26.548% |
| Annexon, Inc. | -193.75 Million USD | 32.156% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 365244.444% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -651.197% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -3641.873% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 112.468% |
| Eyenovia, Inc. | 1.25 Million USD | 10543.457% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 588.578% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -3953.407% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -295.38% |
| Arcellx, Inc. | -296.95 Million USD | 55.734% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -573.905% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -123.273% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -534.207% |
| Moolec Science SA | 117.61 Thousand USD | 111863.706% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -242.332% |
| Geron Corporation | 14.76 Million USD | 990.536% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -246.674% |
| Royalty Pharma plc | 5.65 Billion USD | 102.323% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 7.049% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -1780.727% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -2351.155% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 6.593% |
| Humacyte, Inc. | -22.48 Million USD | -484.595% |
| Structure Therapeutics Inc. | -124.33 Million USD | -5.721% |
| 89bio, Inc. | -289.05 Million USD | 54.523% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -420.767% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -7272.518% |
| Genelux Corporation | -6.89 Million USD | -1805.378% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -323.233% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 257.241% |
| Notable Labs, Ltd. | -9.77 Million USD | -1244.64% |
| Liquidia Corporation | -80.17 Million USD | -63.954% |
| Mustang Bio, Inc. | -3.73 Million USD | -3418.522% |
| Immunovant, Inc. | -635.22 Million USD | 79.306% |
| Quantum-Si incorporated | -118.55 Million USD | -10.877% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -648.417% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -3072.87% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 1737.623% |
| Acasti Pharma Inc. | -23 Million USD | -471.406% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -3803.863% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -708.967% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 4.565% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -4118.124% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -491.274% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -607.911% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 22.345% |
| PepGen Inc. | -60.67 Million USD | -116.667% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -472.127% |
| United Therapeutics Corporation | -507.7 Million USD | 74.108% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -587.295% |
| Solid Biosciences Inc. | -47.75 Million USD | -175.292% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -15148.078% |
| Immuneering Corporation | -54.94 Million USD | -139.252% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -3027.212% |
| Silo Pharma, Inc. | -3.52 Million USD | -3629.867% |
| Belite Bio, Inc | -87.27 Million USD | -50.625% |
| XOMA Corporation | -29 Million USD | -353.283% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -85.937% |
| Bionomics Limited | 227 Million USD | 157.906% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -13.046% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -5089.578% |
| uniQure N.V. | -102.95 Million USD | -27.684% |
| Cassava Sciences, Inc. | -121.13 Million USD | -8.516% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -3055.786% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 420.998% |
| Forte Biosciences, Inc. | -11.96 Million USD | -999.005% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -4148.336% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 124111.321% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -3953.407% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 1576.159% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -1672.546% |
| Altimmune, Inc. | -134.48 Million USD | 2.257% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 166.368% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -5089.578% |
| Compugen Ltd. | -12.9 Million USD | -918.692% |
| Peak Bio, Inc. | 10.34 Million USD | 1371.277% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -46349.47% |
| Benitec Biopharma Inc. | -50.58 Million USD | -159.879% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -25.987% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 769.137% |
| Zura Bio Limited | -99.8 Million USD | -31.708% |
| PolyPid Ltd. | 6.17 Million USD | 2230.502% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 277.35% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 769.137% |
| Instil Bio, Inc. | 75.35 Million USD | 274.437% |
| argenx SE | -2.02 Billion USD | 93.521% |
| Immunome, Inc. | -97.02 Million USD | -35.477% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -484.361% |
| Verona Pharma plc | -220.44 Million USD | 40.369% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -83.226% |
| Shattuck Labs, Inc. | -121.42 Million USD | -8.259% |
| CervoMed Inc. | -7.79 Million USD | -1586.829% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 29.136% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -2905.991% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 0.219% |
| Moolec Science SA | 117.61 Thousand USD | 111863.706% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -5645.337% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 926.826% |
| AnaptysBio, Inc. | -18.15 Million USD | -624.214% |
| Design Therapeutics, Inc. | -18.15 Million USD | -624.253% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -86.772% |
| NeurAxis, Inc. | 145.7 Thousand USD | 90321.002% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 1270.335% |
| Lumos Pharma, Inc. | -28.49 Million USD | -361.348% |
| Achilles Therapeutics plc | -126.92 Million USD | -3.567% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -83.226% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -19946.666% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -532.777% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 9115.127% |
| Nutriband Inc. | -251.65 Thousand USD | -52134.589% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -898.041% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -1666.828% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 138.64% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 653.832% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 70.623% |
| Palisade Bio, Inc. | -12.06 Million USD | -989.712% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 6.314% |
| Beam Therapeutics Inc. | -262.72 Million USD | 49.965% |
| Neurogene Inc. | -131.95 Million USD | 0.381% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 702.549% |
| AEON Biopharma, Inc. | -4.88 Million USD | -2593.689% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 65.15% |
| Sesen Bio, Inc. | -112.55 Million USD | -16.791% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -31.636% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -5498.96% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -236.832% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -57.84% |
| Athira Pharma, Inc. | -88.99 Million USD | -47.701% |
| Vaccinex, Inc. | -1.28 Million USD | -10105.901% |
| HCW Biologics Inc. | 2.85 Million USD | 4701.572% |
| XOMA Corporation | -29 Million USD | -353.283% |
| Nektar Therapeutics | 210.24 Million USD | 162.525% |
| Arvinas, Inc. | -313.8 Million USD | 58.11% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 8199.871% |
| Merus N.V. | -192.88 Million USD | 31.849% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 319.141% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -1794.667% |
| Rezolute, Inc. | -68.16 Million USD | -92.835% |
| Clene Inc. | 3.34 Million USD | 4035.689% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -896.83% |
| BeyondSpring Inc. | -13.75 Million USD | -855.667% |
| Synlogic, Inc. | -6.68 Million USD | -1866.372% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 11691.887% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -1454.725% |
| Peak Bio, Inc. | 10.34 Million USD | 1371.277% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -59.49% |
| Krystal Biotech, Inc. | -350.23 Million USD | 62.467% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 205.903% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 22.216% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -4063.637% |
| MannKind Corporation | 143.89 Million USD | 191.35% |
| Ikena Oncology, Inc. | -109.15 Million USD | -20.426% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -1636.257% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -297.136% |
| Gossamer Bio, Inc. | 180.35 Million USD | 172.885% |
| CohBar, Inc. | -5.93 Million USD | -2116.455% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -341.885% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 2978.931% |
| Legend Biotech Corporation | -949.39 Million USD | 86.154% |
| Mural Oncology plc | -255.84 Million USD | 48.62% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 508.046% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -2690.533% |
| Disc Medicine, Inc. | -358.28 Million USD | 63.31% |
| Champions Oncology, Inc. | 4.81 Million USD | 2831.754% |
| REGENXBIO Inc. | 54.76 Million USD | 340.016% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -48783.815% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 12.96% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -1358.632% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -62.924% |
| Vaxart, Inc. | -8.24 Million USD | -1495.098% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -161.961% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -3.371% |
| Cellectis S.A. | -43.85 Million USD | -199.742% |
| Longeveron Inc. | -2.9 Million USD | -4420.358% |
| Repare Therapeutics Inc. | -107.85 Million USD | -21.875% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 113.574% |
| Inozyme Pharma, Inc. | 12 Million USD | 1195.068% |
| Revolution Medicines, Inc. | -608.2 Million USD | 78.387% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -10587.154% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 50.417% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 12.407% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -740.11% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -17663.784% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 98.626% |
| Denali Therapeutics Inc. | -74.86 Million USD | -75.585% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -996.191% |
| Veru Inc. | 4.77 Million USD | 2850.06% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1068.878% |
| Cingulate Inc. | 3.08 Million USD | 4364.208% |
| Passage Bio, Inc. | 4.58 Million USD | 2967.001% |
| Context Therapeutics Inc. | -14.44 Million USD | -809.713% |
| Exicure, Inc. | 5.84 Million USD | 2347.427% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 42.94% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -232.201% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 937.754% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -123.478% |
| Nuvalent, Inc. | -335.38 Million USD | 60.806% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 7679.363% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -76.488% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -1378.65% |
| OmniAb, Inc. | 9.2 Million USD | 1528.36% |
| Anew Medical, Inc. | 1.43 Million USD | 9276.629% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 902.429% |
| Lipocine Inc. | -4.75 Million USD | -2664.738% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -19.689% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 963.056% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -159.484% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 628.089% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -1855.84% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -99.693% |
| Ocugen, Inc. | -32.52 Million USD | -304.207% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -53.61% |
| Q32 Bio Inc. | -37.94 Million USD | -246.4% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -20831.847% |
| Alumis Inc. Common Stock | -13.52 Million USD | -871.631% |
| Equillium, Inc. | -22.39 Million USD | -487.049% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -414.127% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -302.896% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -52923.012% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 198.068% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 4210.444% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 40123.018% |
| Dominari Holdings Inc. | 195 Thousand USD | 67511.282% |
| Edesa Biotech, Inc. | -5.26 Million USD | -2395.809% |
| vTv Therapeutics Inc. | -8.91 Million USD | -1374.173% |
| Bio-Techne Corporation | 267.74 Million USD | 149.096% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -710.982% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -11.311% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -1464.346% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -939.064% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 46.372% |
| Nkarta, Inc. | 57.29 Million USD | 329.414% |
| BioCardia, Inc. | 212 Thousand USD | 62105.66% |
| Iterum Therapeutics plc | 13.43 Million USD | 1078.211% |